MyBiotics Pharma
Clinically Effective Microbiome and Probiotic Products
StartupMyBiotics Pharma is a Rehovot-based startup in the Health Tech & Life Sciences sector, established in 2014. Clinically Effective Microbiome and Probiotic Products. The company has raised a total of $11.27M across 5 funding rounds, currently at the A stage. MyBiotics Pharma was founded by Didi Daboush. Key investors include Maruho Israel Innovation Fund. The company has 11-50 employees. Core technologies: Biologicals, Microorganisms.
With $11.27M in total funding, MyBiotics Pharma is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2B/B2C business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageA
- ProductClinical Trial
- ModelB2B, B2C
- Employees11-50
- HQRehovot
- DistrictCenter District
- Last RoundUndisclosed
- Maruho Israel Innovation Fund
Didi DaboushCo-founder & CEO
9 articles covered by sources including www.prnewswire.com,
www.timesofisrael.com,
www.biospace.com,
www.geektime.com,
en.globes.co.il.
What does MyBiotics Pharma do?
MyBiotics Pharma is a microbiome company focused on bettering peoples lives and health by greatly improving on existing probiotic solutions. MyBiotics has developed a novel technological platform for the development of microbiome-related drugs and supplements. The companys platform uses innovative formulation, delivery, and culturing methods designed to provide better viability and resistance, and potentially improved colonization and clinical results. Based on this proprietary innovation, MyBiotics has developed three main technologies: MyCrobe, SuperDonor, and Super Donor Select, which are all supported by MyLiveIn, a computational and AI technology platform. After targeting specific medical indications, MyBiotics has now reached the clinical stage with three products. Based on the companys SuperDonor technology, its MBX-SD-201 and MBX-SD-202 products offer safe and reproducible microbiome restoration and may become an alternative for complete microbiome recovery and design using fecal microbiota transplantation. MyBiotics has initiated significant collaborations and development agreements with a variety of pharmaceutical companies and clinical partners in the areas of C. diff, oncology, dermatology, and womens health.
How much funding has MyBiotics Pharma raised?
MyBiotics Pharma has raised $11.27M in total funding across 5 rounds. The company is currently at the A stage. Key investors include Maruho Israel Innovation Fund.
Who founded MyBiotics Pharma?
MyBiotics Pharma was founded in 2014 by Didi Daboush (Co-founder & CEO).
What sector is MyBiotics Pharma in?
MyBiotics Pharma operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drug Delivery, Drugs Discovery & Development, Biomaterials & Tissue Engineering, with core technologies in Biologicals, Microorganisms. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Life Sciences, Pharmaceuticals, Consumers, Recreational & Lifestyle, Fitness & Sports.
Where is MyBiotics Pharma located?
MyBiotics Pharma is based in Yitzhak Modai St 2, Rehovot, Israel, Center District.